Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ionizable lipid nanoparticles for RAS protease delivery to inhibit cancer cell proliferation

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.05.015Source: DataRank Database

Ionizable lipid nanoparticles for RAS protease delivery to inhibit cancer cell proliferation is a research paper published in Journal of Controlled Release (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 2.40)OA: greenTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Rebecca M. Haley ORCID,Margaret M. Billingsley ORCID,Alexander Chan,Biao Ruan ORCID,Christian G. Figueroa‐Espada ORCID

Live enrichment

PubMed:38729436 PMC:PMC11210981 OpenAlex:https://openalex.org/W4396838305

National Institutes of Health

Grant: DP2 TR002776

National Institutes of Health

Grant: R01 GM141290

National Institutes of Health

Grant: F31 CA260922

American Cancer Society

Grant: RSG-22-122-01-ET

National Science Foundation

Grant: CBET-2145491

Abramson Cancer Center

Grant: SCR 022376

Abramson Cancer Center

Grant: P30 016520

Canadian Aeronautics and Space Institute

Burroughs Wellcome Fund

FWCI

2.40

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11210981/pdf/nihms-1996234.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0168365924002992?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365924002992?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11210981

Fields of Study

RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryAdvanced biosensing and bioanalysis techniques

MeSH Terms

AnimalsAntineoplastic AgentsFemaleHumansLipidsMice, NudeNeoplasmsTissue DistributionProto-Oncogene Proteins p21(ras)Drug Delivery Systemsras ProteinsCell Line, TumorCell ProliferationMiceNanoparticles

Keywords

In vivoCancer cellCell growthChemistryIn vitroCancerProteaseCancer researchBiologyBiochemistryEnzymeRasDrug DeliveryProtein TherapeuticsLipid Nanoparticles

Sustainable Development Goals

SDG 0: Good health and well-being

Ionizable lipid nanoparticles for RAS protease delivery to inhibit cancer cell proliferation

FAIR Checklist

Authors (10)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)